Literature DB >> 8798973

Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity.

A Dudhane1, B Conti, T Orlikowsky, Z Q Wang, N Mangla, A Gupta, G P Wormser, M K Hoffmann.   

Abstract

Monocytes/macrophages control the function of lymphocytes through positive and negative regulation. They release immunostimulatory cytokines and initiate costimulatory signals in T cells through the expression of B7 molecules. Their negative regulatory functions include the capacity to destroy cells with which they form cellular conjugates. We show here that HIV-1 infection skews monocyte function toward negative regulation by restraining the expression of costimulatory B7 molecules and by enhancing the cytolytic monocyte function. Monocytes that express constitutively B7, a membrane component that facilitates the engagement of costimulatory signals in T cells, lose this marker after HIV-1 infection and become refractory to inducers of B7 expression. The appearance of monocytes with reduced B7 expression is associated with an increased cytolytic monocyte capacity. Monocytes from HIV-1-infected donors destroy antibody-targeted normal lymphocytes more efficiently than do normal monocytes and they destroy CD4+ T cells specifically without the exposure to an exogenous ligand. CD4-reactive HIV-1 envelope molecules, expressed on monocytes as a consequence of infection or of opsonization by antibody, may specifically target CD4+ T lymphocytes for destruction and may thereby contribute to the preferential loss of CD4 T cells in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798973     DOI: 10.1089/aid.1996.12.885

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10.

Authors:  T Orlikowsky; T Olikowsky; Z Q Wang; A Dudhane; H Horowitz; B Conti; M K Hoffmann
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

3.  Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation.

Authors:  Z Q Wang; A S Bapat; R J Rayanade; A S Dagtas; M K Hoffmann
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

4.  The Role of Antigen-presenting Cells in HIV Pathogenesis.

Authors:  Claire Chougnet; Gene M. Shearer; Alan L. Landay
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

5.  Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS.

Authors:  Odin Goovaerts; Wim Jennes; Marguerite Massinga-Loembé; Ann Ceulemans; William Worodria; Harriet Mayanja-Kizza; Robert Colebunders; Luc Kestens
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

6.  HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.

Authors:  Emmanouil Papasavvas; Elizabeth C Moore; Junwei Sun; Livio Azzoni; Maxwell Pistilli; Karam Mounzer; Jane Shull; Jay R Kostman; Luis J Montaner
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

7.  Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Authors:  Woong-Ki Kim; Yue Sun; Hien Do; Patrick Autissier; Elkan F Halpern; Michael Piatak; Jeffrey D Lifson; Tricia H Burdo; Michael S McGrath; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

Review 8.  HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.

Authors:  Rachel P J Lai; Graeme Meintjes; Robert J Wilkinson
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.